Trial Profile
Phase I drug-interaction study of CK 2017357 given in combination with riluzole in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jun 2012
Price :
$35
*
At a glance
- Drugs Tirasemtiv (Primary) ; Riluzole
- Indications Amyotrophic lateral sclerosis; Anxiety disorders; Cachexia; Huntington's disease; Muscle fatigue; Muscular atrophy; Myasthenia gravis; Parkinson's disease; Psychotic disorders
- Focus Pharmacokinetics
- 28 Jul 2011 Status changed from recruiting to active, no longer recruiting.
- 18 May 2011 Status changed from planning to recruiting.
- 16 Feb 2011 New trial record